Benefit or Harm? Arguments for and Against Early Detection of Dementia in Primary Care

TL;DR

This paper discusses the debate over whether early dementia detection in primary care is beneficial or harmful, considering clinical, equity, and system readiness factors.

Contribution

The paper provides a balanced analysis of arguments for and against early dementia detection in primary care, highlighting tensions between potential benefits and healthcare system limitations.

Findings

Proponents argue early detection allows for better symptom management and access to treatments.

Opponents highlight insufficient evidence of benefit and risks of premature screening without proper infrastructure.

The debate underscores the need to address health equity and system readiness in dementia care.

Abstract

There is an ongoing debate over the value of early dementia detection in primary care settings. Routine screening of adults aged 65+ aligns with the Affordable Care Act’s Annual Wellness Visit requirements but is in opposition to the 2020 U.S. Preventive Services Task Force’s “insufficient evidence”, and therefore negative, recommendation for universal screening. Proponents emphasize that over half of dementia cases go undiagnosed with people from racial and ethnic minority backgrounds disproportionately affected. They argue that primary care providers’ long-standing relationship with patients positions them well to identify subtle cognitive changes and implement early interventions, such as hearing correction, which may slow cognitive decline regardless of etiology. Early detection enables patients and families to better manage symptoms, access treatments or therapies, and engage in care planning for future needs. Opponents supports the U.S. Preventive Services Task Force’s position against routine screening, citing insufficient evidence of benefit. They argue that primary care providers face significant time constraints, and without clear post-diagnosis interventions, screening may be premature. They emphasize fundamental gaps in provider preparedness to identify cognitive impairment and provide support and resources. Opponents contend that widespread screening without robust dementia-capable infrastructure risks causing potential harm to patients and caregivers. This debate illuminates critical tensions between the potential benefits of early detection and healthcare system limitations. A full discussion, however, should extend beyond clinical considerations to encompass broader questions of health equity, workforce development, and system readiness. These complexities necessitate careful consideration of how to ensure the earliest actionable detection of dementia.